EPHA3 and small cell lung carcinoma: EphA3 upregulation in small-cell lung cancer (SCLC) lowered therapeutic resistance by promoting apoptosis and triggering G0/G1 arrest, which was associated with decreased phosphorylation of the PI3K/BMX/STAT3 signalling [74].